Dr. Nora D. Volkow to receive Aebersold Award

June 22, 2003

Nora D. Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health and a leader in drug addiction research, is the recipient of the 2003 Society of Nuclear Medicine's (SNM) 2003 Paul C. Aebersold Award for outstanding achievement in basic science applied to nuclear medicine. The award will be presented at the Society's 50th Annual Meeting.

The first woman to serve as NIDA's director, Dr. Volkow has a long history of accomplishment in drug addiction research. Her work has focused on the dopamine systems in the brains of addicted, obese, and aging individuals. She was the first to use imaging to investigate the neurochemical changes associated with addiction. She has produced more than 290 peer-reviewed publications, more than 50 book chapters, edited three books and has received numerous awards, including designation as U.S. News and World Report's "Innovator of the Year" for 2000.

Dr. Volkow earned her BA from Modern American School in Mexico City, Mexico and her MD from the National University of Mexico in Mexico City. She did her postdoctoral training in psychiatry at New York University in New York City. Prior to joining NIDA, she was associate director for life sciences, director of nuclear medicine, and director of the NIDA-Department of Energy Regional Neuroimaging Center at Brookhaven National Laboratory. Dr. Volkow was also a professor in the department of psychiatry and associate dean of the medical school at the State University of New York (SUNY), Stony Brook.

The Aebersold Award is named for Dr. Paul C. Aebersold, a pioneer in the biologic and medical application of radioactive materials and the first Director of the Atomic Energy Commission's Division of Isotope Development at Oak Ridge, Tennessee. The first Aebersold Award was given by SNM in 1973.

Society of Nuclear Medicine

Related Addiction Articles from Brightsurf:

Opioid addiction treatment is more widely available, but only for adults
Primary care providers have expanded access to buprenorphine for adults, but use of the opioid addiction treatment has decreased among the youngest patients, find researchers at Columbia University.

Is video game addiction real?
A recent six-year study, the longest study ever done on video game addiction, found that about 90% of gamers do not play in a way that is harmful or causes negative long-term consequences.

Eating disorders linked to exercise addiction
New research shows that exercise addiction is nearly four times more common amongst people with an eating disorder.

Co-addiction of meth and opioids hinders treatment
A study published in the Journal of Substance Abuse Treatment found that methamphetamine use was associated with more than twice the risk for dropping out of treatment for opioid-use disorder.

New tool to assess digital addiction in children
A new study developed and validated a tool for assessing children's overall addiction to digital devices.

Addiction intervention in hospital is a 'reachable moment'
Patients who meet an addiction medicine consult team while they're in the hospital are twice as likely to participate in treatment for substance use disorder after they go home, according to new research.

How stress leads to Facebook addiction
Friends on social media such as Facebook can be a great source of comfort during periods of stress.

Systematic review of food addiction as measured with the Yale Food Addiction Scale
The aim of this paper was to review the clinical significance of food addiction diagnoses made with the Yale Food Addiction Scale (YFAS) and to discuss the results in light of the current debate on behavioral addictions.

Drugs of abuse: Identifying the addiction circuit
What happens in the brain of a compulsive drug user?

Pancreatic cancer's addiction could be its end
Researchers at CSHL have discovered that an inappropriately produced protein may be why some pancreatic cancer patients die exceptionally early.

Read More: Addiction News and Addiction Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.